You are here :

  1. Home
  2. Investors

Change language :

Français

Investors

Let’s meet together

the challenges of the future

IR center

EXTEL 2010 Pan European Awards / Investor Relations
#1 in France (CAC 40)
#1 European Pharmaceutical Company
Sanofi-aventis thanks investors and analysts for the support shown by their votes

EURONEXT Paris (SAN)

Last update: Sept 02, 2010 05.35 PM (CET)
Quote: €46.38. Level change: -0.52%

NYSE (SNY)

Last update: Sept 02, 2010 01.02 PM (EST)Quote: $29.69. Level change: -0.04%

 

Focus

August 30, 2010

Sanofi-aventis non-binding offer to acquire Genzyme

The sanofi-aventis non-binding offer was discussed by the management during a live audio webcast.


July 29, 2010

Second Quarter 2010 Results

 
The Second Quarter 2010 results were reviewed by management during a live audio webcast.


July 9, 2010

Sanofi-aventis in China – Presentation, Shanghai

Thomas Kelly, Sanofi-aventis’ Vice President, Greater China and Eric NG, Vice-President, Business Innovation & Excellence participated.


July 1, 2010

Emerging Markets Presentation - Paris

Olivier Charmeil, Vice President, Pharmaceutical Operations, Asia Pacific & Japan, Patrick Aghanian, Country & General Manager, Russia and Heraldo Marchezini, General Manager, Brazil presented on Emerging Markets


June 30, 2010

Investor conference call moderated by Morningstar

Picture of Thomas Kelly

Thomas Kelly, Sanofi-Aventis' Vice President, Greater China presented during the conference call.


June 15, 2010

Goldman Sachs Healthcare Conference

Picture of Jerôme Contamine

Jérôme Contamine, Executive VP, Chief Financial Officer, presented at the conference in Los Angeles.

Upcoming events

Bank of America - Merrill Lynch Healthcare Conference

September 15, 2010
Christopher A. Viehbacher, CEO, will present at the Conference in London.
 

IR Thematic Seminar on Diabetes & Oncology

September 30, 2010